The risk factors for febrile neutropenia during chemotherapy in children with malignancy

• Κύριοι συγγραφείς: Rini Sulviani (Συγγραφέας), Ponpon Idjradinata (Συγγραφέας), Harry Raspati (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Indonesian Pediatric Society Publishing House, 2007-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background Febrile neutropenia is the most common side effect of myelosuppressive chemotherapy. It is important to identify its risk factors to decrease the morbidity and mortality of febrile neutropenia. Objective To identify whether age, type of malignancy, phase and dose of chemotherapy, nutritio...